Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials Read More > January 7, 2021
Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression Read More > December 23, 2020
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics Read More > December 21, 2020
Ketamine as an adjunctive therapy for major depression – a randomised controlled pragmatic pilot trial (Karma-Dep Trial) Read More > December 16, 2020
Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study Read More > December 11, 2020
Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression Read More > December 11, 2020
Neural Mechanisms Underlying the Rewarding and Therapeutic Effects of Ketamine as a Treatment for Alcohol Use Disorder Read More > December 10, 2020
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation Read More > December 10, 2020
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine Read More > December 10, 2020
